Showing results (2671-2680 of 9,180) with videos related to
Sort By:
Pageof 918
Cancer Medicine|March 29, 2022
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patientsCameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, et al.Cancer Medicine|March 29, 2022
Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expressionHua-Lin Chen, Yi-Ping Luo, Mu-Wen Lin, et al.Cancer Medicine|May 16, 2018
Predictive impact of the inflammation-based indices in colorectal cancer patients with adjuvant chemotherapyYong Tao, Lei Ding, Guan Gen Yang, et al.Cancer Medicine|May 16, 2018
FM19G11 inhibits O6 -methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditionsChao-Guo You, Han-Song Sheng, Chao-Ran Xie, et al.Cancer Medicine|December 9, 2023
Differential co-expression network analysis elucidated genes associated with sensitivity to farnesyltransferase inhibitor and prognosis of acute myeloid leukemiaNurdan Kelesoglu, Medi Kori, Betul Karademir Yilmaz, et al.Cancer Medicine|December 8, 2023
Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survivalKyoko Oura, Asahiro Morishita, Kei Takuma, et al.Cancer Medicine|December 8, 2023
Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinomaSumei Zhang, Yike Gao, Pan Wang, et al.Cancer Medicine|December 8, 2023
Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real worldYamei Zhai, Qingya Wang, Li Ji, et al.Cancer Medicine|December 7, 2023
Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancerLuyi Lin, Haiming Li, Xin Wang, et al.Cancer Medicine|December 9, 2023
Utilization of cardiac tests in anthracycline-treated cancer survivors differs between young adults and children: A claims-based analysisXu Ji, Xin Hu, Joseph Lipscomb, et al.Pageof 918